Zhejiang Sanhua Said to Upsize Hong Kong Listing to $1.2 Billion

Zhejiang Sanhua Intelligent Controls Co. raised HK$9.3 billion ($1.2 billion) after expanding the size of its Hong Kong share sale and pricing the deal at the top of the marketed range, according to people familiar with the matter.
The Chinese company, whose stock also trades in Shenzhen, priced 414.4 million shares in its Hong Kong listing at HK$22.53 each, the people said, asking not to be named because the information isn't public.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

36 minutes ago

• Yahoo

Public companies account for 71% of Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) ownership, while individual investors account for 19%

The considerable ownership by public companies in Gyre Therapeutics indicates that they collectively have a greater say in management and business strategy 71% of the company is held by a single shareholder (GNI Group Ltd.) Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. If you want to know who really controls Gyre Therapeutics, Inc. (NASDAQ:GYRE), then you'll have to look at the makeup of its share registry. With 71% stake, public companies possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk). Individual investors, on the other hand, account for 19% of the company's stockholders. In the chart below, we zoom in on the different ownership groups of Gyre Therapeutics. See our latest analysis for Gyre Therapeutics Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Institutions have a very small stake in Gyre Therapeutics. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment. If the business gets stronger from here, we could see a situation where more institutions are keen to buy. We sometimes see a rising share price when a few big institutions want to buy a certain stock at the same time. The history of earnings and revenue, which you can see below, could be helpful in considering if more institutional investors will want the stock. Of course, there are plenty of other factors to consider, too. We note that hedge funds don't have a meaningful investment in Gyre Therapeutics. GNI Group Ltd. is currently the largest shareholder, with 71% of shares outstanding. This implies that they have majority interest control of the future of the company. Meanwhile, the second and third largest shareholders, hold 3.1% and 3.1%, of the shares outstanding, respectively. Songjiang Ma, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track. The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. We can see that insiders own shares in Gyre Therapeutics, Inc.. In their own names, insiders own US$53m worth of stock in the US$755m company. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying. The general public, who are usually individual investors, hold a 19% stake in Gyre Therapeutics. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders. It appears to us that public companies own 71% of Gyre Therapeutics. It's hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it's worth watching this space for changes in ownership. It's always worth thinking about the different groups who own shares in a company. But to understand Gyre Therapeutics better, we need to consider many other factors. Like risks, for instance. Every company has them, and we've spotted 2 warning signs for Gyre Therapeutics (of which 1 makes us a bit uncomfortable!) you should know about. If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Yahoo

44 minutes ago

• Yahoo

Here's How Much a $30,000 Investment in the Nasdaq 100 Today Could Be Worth in 30 Years

Investors can gain exposure to top growth stocks like Amazon and Nvidia by investing in the Invesco QQQ Trust. The exchange-traded fund has averaged a compound annual return of more than 18% over the past decade. Investing $30,000 into the fund today could potentially result in your portfolio being worth over $1 million in the future. 10 stocks we like better than Invesco QQQ Trust › Growth stocks can generate returns far superior to those of value stocks or dividend stocks in the long run. These are the types of companies that investors are drawn to because if they're growing, they are expanding their operations and likely innovating and potentially diversifying along the way. Names like Amazon and Nvidia are two exceptional examples. Over the past 20 years, the former has produced returns of 12,000% while the latter is up more than 60,000%. Investing $30,000 into either one of the stocks back then would have made you millions of dollars. Picking the next big growth stock is easier said than done. But the good news is that you don't have to pick the next Amazon or Nvidia to achieve great results. The Invesco QQQ Trust (NASDAQ: QQQ) is an exchange-traded fund (ETF) that will give you exposure to the top 100 nonfinancial stocks in the Nasdaq exchange, also known as the Nasdaq 100. Amazon, Nvidia, and many other top tech names are included in that list. Here's how a $30,000 investment in the fund might grow over the long haul. The best growth stocks in the world are often found on the Nasdaq. And by targeting the top 100 nonfinancial companies, you won't have to worry about keeping an eye on which growth stocks to buy. The Invesco fund will adjust its holdings over time, removing poor-performing stocks and replacing them with rising stars. Some of the top holdings in the ETF today include Costco Wholesale, Netflix, and Broadcom. While it is a tech-heavy fund (tech stocks account for 57% of its holdings), about 20% of the portfolio is also in consumer discretionary stocks, followed by smaller positions in other sectors. And more than 97% of the holdings are U.S. stocks, which can minimize your exposure to international markets. It's little surprise, with so much focus on growth, that the Invesco QQQ Trust widely outperformed the S&P 500 over the past decade. At 430%, it has averaged a compound annual growth rate of more than 18%. As impressive as the Invesco ETF's returns have been over the past decade, they've also been skewed in recent years by a flurry of tech spending, which may not persist in the very long term. That's why it may be a good idea to scale back expectations of what its future returns may look like. Rather than 18%, perhaps closer to the long-run average of 10% for the S&P 500 might be appropriate. The table below shows what a $30,000 investment might grow to at varying rates after 30-plus years. Years 9% Growth 10% Growth 11% Growth 12% Growth 13% Growth 30 $398,030 $523,482 $686,769 $898,798 $1,173,477 31 $433,853 $575,830 $762,313 $1,006,653 $1,326,029 32 $472,900 $633,413 $846,168 $1,127,452 $1,498,413 33 $515,461 $696,755 $939,246 $1,262,746 $1,693,206 34 $561,852 $766,430 $1,042,564 $1,414,276 $1,913,323 35 $612,419 $843,073 $1,157,246 $1,583,989 $2,162,055 Table and calculations by author. There's no way to know what growth rate the Invesco ETF will end up averaging, especially when you're looking at such a long period of time. But the big takeaway is that with the effects of compounding, you can potentially build up a significant portfolio simply by putting $30,000 into a top growth fund like the Invesco QQQ Trust and letting it sit. It's a perfect example of a buy-and-forget type of investment. Before you buy stock in Invesco QQQ Trust, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Invesco QQQ Trust wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Costco Wholesale, Netflix, and Nvidia. The Motley Fool recommends Broadcom and Nasdaq. The Motley Fool has a disclosure policy. Here's How Much a $30,000 Investment in the Nasdaq 100 Today Could Be Worth in 30 Years was originally published by The Motley Fool

Yahoo

an hour ago

• Yahoo

Retiring in 2026? 6 Reasons You Should Delay Those Plans

At nearly halfway through 2025, some folks may be eyeballing 2026 for retirement for any number of reasons. Find Out: Read Next: Getting to that point is a great accomplishment if you're well prepared, but if you aren't, you could be putting yourself in a state of undue stress right as you hope to be relaxing into a more leisurely life. Financial experts suggested some reasons you might want to delay a 2026 retirement. If you haven't thoroughly mapped out your retirement income sources, projected expenses (including potential long-term care costs), and developed a solid investment strategy to address any shortfalls and market volatility, it may be wise to delay retirement, according to Christine Lam, a CFP and investment advisor representative at Financial Investment Team. 'Typically, retirement planning conversations begin five to 10 years ahead of a projected retirement date,' she said. She strongly recommended consulting a financial planner for a comprehensive retirement analysis and cash flow projection well before retirement. Learn More: Social Security benefits are calculated based on your highest 35 years of earnings, Lam said. If your work history includes several years with little or no income, continuing to work could help replace those lower-earning years with higher-income ones, which increases your future Social Security benefits, she pointed out. 'Additionally, delaying the start of Social Security benefits beyond full retirement age (generally age 67) can result in a permanent increase in your monthly payout,' she said. Careful Social Security planning is a key part of retirement planning. Unfortunately, in 2026, you may still be retiring into a time of elevated interest rates, sticky inflation and uneven market performance, all of which can disrupt portfolio withdrawals and reduce purchasing power, according to Christopher Stroup, CFP and owner of Silicon Beach Financial. 'Retiring into volatility without a plan for sequencing risk, especially for equity-heavy portfolios, can erode long-term wealth,' he said. These times require flexibility and proactive planning. People retiring before age 65 should consider the implications of losing employer-sponsored health insurance, Lam said. 'Since Medicare eligibility begins at age 65, those with ongoing health issues may find it beneficial to remain employed in order to maintain coverage,' she said. Stroup agreed, saying that the cost of rising out-of-pocket expenses and Medicare premiums can eat into fixed retirement income. 'Delaying retirement gives you time to build a health savings account (HSA), extend employer coverage or optimize Medicare enrollment to avoid late penalties and income-related premium surcharges,' Stroup said. An added benefit of delaying your retirement and working longer is that it may allow you to delay required minimum distributions (RMDs), the payments you are required to take from your retirement accounts by age 70. This means you can avoid tapping taxable accounts too soon and can contribute more to retirement plans, Stroup explained. 'Entrepreneurs can also better time business exits to manage capital gains and harvest deductions strategically,' he said. The stock market has been volatile this year, largely due to tariff trade wars, but if you were to retire into an economic downturn, you risk 'locking in investment losses by withdrawing at depressed values,' Stroup said. Thus, delaying retirement gives your portfolio more time to recover and reduces the number of years you'll rely on it for income. Before retiring, use this checklist to make sure you're ready. Here's what you should have: A reliable income stream that covers essential expenses Adequate emergency and healthcare reserves A tax-efficient withdrawal strategy A plan for long-term care and inflation protection Confidence that your portfolio can weather market shocks As with all significant financial planning, if you can work with a trusted financial advisor, you'll rest assured that you've covered all your bases by retirement. More From GOBankingRates 25 Places To Buy a Home If You Want It To Gain Value This article originally appeared on Retiring in 2026? 6 Reasons You Should Delay Those Plans Sign in to access your portfolio